LFMDP News and Press, LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock From 06/09/25

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of June: BTIG Obesity Health Forum, June 1...

2025-06-05 09:05:35 ET Summary Hims & Hers Health, Inc. has seen massive success, aided by the growing use of GLP-1 drugs. The company outlined an ambitious $6.5 billion 2030 revenue target. Risks are rising. FDA's decision to determine the GLP-1 shortage as resolved makes Him...

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy ® (semaglutide), which includes both the medication...

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of May: H.C. Wainwright 3 rd Annual...

2025-05-09 10:24:24 ET Summary LifeMD grew its fiscal 2025 first quarter revenue by 48.8% over its year-ago comp. The company ended the first quarter with cash and cash equivalents of $34.4 million. Adjusted EBITDA was $8.7 million. Stagflation risks could spark some volatilit...

2025-05-06 18:48:25 ET More on LifeMD, LifeMD, Inc. 8.875% CUM PFD A, etc. LifeMD, Inc. (LFMD) Q1 2025 Earnings Call Transcript LifeMD Is Back To Life LifeMD, Inc. (LFMD) Q4 2024 Earnings Call Transcript LifeMD Q1 2025 Earnings Preview Hims & Hers...

2025-05-06 18:47:39 ET LifeMD, Inc. (LFMD) Q1 2025 Earnings Conference Call May 6, 2025, 4:30 PM ET Company Participants Justin Schreiber - Chairman and CEO Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG Sarah...

Total revenues increased 49% year-over-year to $65.7 million with telehealth revenue up 70% Adjusted EBITDA increased to $8.7 million from $0.1 million in the year-ago period Telehealth adjusted EBITDA increased to $5.3 million from a loss of $1.3 million in the year-ago period GAAP n...

2025-05-05 18:48:26 ET LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 1.63%. The average open to low on the day of e...

2025-05-05 18:43:25 ET LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in LFMDP stock price following earnings has aver...